Closing Bell: Eupraxia Pharmaceuticals Inc down on Tuesday (EPRX)

Eupraxia Pharmaceuticals Inc opened trading today at $3.65 and closed at $3.40. It traded at a low of $3.40 to a high of $3.65.

Share prices dipped -5.03% from the previous day's close of $3.58.

Today across North America, the TSX Composite closed -2.18% at 22227.63, the S&P 500 closed -3.00% at 5186.33, the Dow Jones Industrial Average closed -2.60% at 38703.27 and the Nasdaq Composite closed -3.43% at 16200.08.

Eupraxia Pharmaceuticals Inc traded under EPRX on the Toronto Stock Exchange (TSX).

A total of 39,223 shares was traded during the last trading day, with total trades of 99, with an average volume of 19,279 over 5 days.

The TSX market on the whole today saw 3,772 price advancers against 1,443 declines and 86 unchanged.

During the prior 52 weeks, EPRX.TO has traded as high as $8.46 (August 15,2023) and low as $3.25 (July 05,2024). Moreover, the shares have shrunken -54.48 percent in the last 52 weeks, while this year, they have dipped -36.69%.

Following today's trading, Eupraxia Pharmaceuticals Inc has a market capitalization of $127.53 million on a float of 35,623 shares outstanding. Its annual EPS is $-1.20.

Eupraxia Pharmaceuticals Inc is a TSX Biotechnology company headquartered in Victoria, CAN.

Eupraxia Pharmaceuticals Inc is holding an average recommendation of "Strong Sell" from 0.00 analysts according to Zacks. Currently, there are for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..